Health
Cardioprotective therapies fail to prevent LVEF decline in early breast cancer treatment – Healio
Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly protective against minor…
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly protective against minor long-term decline in left ventricular ejection fraction, a speaker reported.
According to data presented at the virtual American College of Cardiology Scientific Session, concomitant…
-
Noosa News22 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News24 hours agoHow to get the most from potted citrus and when they’ll fruit
-
General23 hours agoPeter Dutton partially walks back public service work-from-home vow
-
General16 hours agoIran’s currency at record low as tensions run high